Abeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type A
01 févr. 2017 07h43 HE
|
Abeona Therapeutics Inc
ABO-102, the leading clinical gene therapy program for Sanfilippo syndrome type A patients, has demonstrated central nervous system (CNS) and peripheral organ disease biopotencyFirst high dose cohort...
Insight Pharma Reports' Gene Therapy Market Report: Moving Toward Commercialization
23 sept. 2016 13h00 HE
|
Insight Pharma Reports
NEEDHAM, MA--(Marketwired - September 23, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, releases "Gene Therapy: Moving Toward Commercialization" an in-depth life science market...
Gene Therapy: Moving Toward Commercialization
11 mai 2016 10h50 HE
|
Insight Pharma Reports
NEEDHAM, MA--(Marketwired - May 11, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, releases "Gene Therapy: Moving Toward Commercialization" an in-depth life science market...